Effect of immunization against somatostatin in the pregnant ewe on growth and endocrine status of the neonatal lamb.
Absorption of somatostatin (SRIF) specific antibodies from colostrum of ewes actively immunized against SRIF may improve growth rate of the neonatal lamb by neutralizing the inhibitory effects of SRIF on pituitary and thyroid function. Growth and endocrine parameters in the offspring of SRIF immunized (SI) and control (C) crossbred ewes were examined. Lamb weight was recorded at birth and twice each week to 24 days of age. Blood samples were collected prior to first suckle and twice each week. At 21 to 24 days of age, in separate experiments, lambs were infused with glucose (0.29 g/kg), arginine (0.25 g/kg) or thyrotropin-releasing hormone (TRH; 0.33 microgram/kg). A strong correlation (R = 0.88; P less than .01) was observed between anti-SRIF titre in the ewe at parturition and in the lamb at 3 days of age. No effect on lamb birth weight (SI 4.28 +/- 0.27 kg; C 4.35 +/- 0.23 kg) was observed. At 24 days of age cumulative gain in SI lambs (5.4 +/- 0.32 kg) was greater (P less than .05) than in C lambs (4.5 +/- 0.32 kg). The growth hormone secretory responses to glucose or arginine were not affected by treatment. Plasma IGF-I, plasma thyroxine (T4) and the plasma thyrotropin and T4 responses to TRH were not different between treatments. Plasma triiodothyronine (T3) was higher (P less than .05) in SI (2.46 +/- .10 ng/ml) than in C (2.01 +/- .05 ng/ml) lambs, however, the plasma T3 response to TRH was lower in SI lambs. Plasma glucose (mg/dl) was higher (P less than .05) in SI (118.4 +/- 1.7) than in C (106.0 +/- 4.0) lambs. Plasma insulin was not affected by treatment. Increased plasma T3 and glucose concentrations during SRIF immunoneutralization in the neonate lamb may be important factors contributing to the growth response observed.
Van Kessel
A G
AG
Department of Animal and Poultry Science, University of Saskatchewan, Saskatoon, Canada.
Korchinski
R S
RS
Hampton
C H
CH
Laarveld
B
B
D000818:Animals; D000831:Animals, Newborn / Q000254:growth & development*; D000833:Animals, Suckling / Q000254:growth & development*; D001120:Arginine / Q000494:pharmacology; D001724:Birth Weight; D003126:Colostrum / Q000276:immunology; D005260:Female; D005947:Glucose / Q000494:pharmacology; D013006:Growth Hormone / Q000097:blood; D007112:Immunity, Maternally-Acquired; D007328:Insulin / Q000097:blood; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000276:immunology*; D012756:Sheep / Q000254:growth & development* / Q000276:immunology; D013004:Somatostatin / Q000276:immunology*; D013963:Thyroid Hormones / Q000097:blood; D013972:Thyrotropin / Q000097:blood; D015430:Weight Gain
D007328:Insulin; D013963:Thyroid Hormones; D013004:Somatostatin; D013972:Thyrotropin; D013006:Growth Hormone; D001120:Arginine; D005947:Glucose